Efavirenz D5
| Product Name | Efavirenz D5 |
|---|---|
| Alternate Names | Efavirenz Stable Isotopes, Stable Isotopes of Efavirenz |
| CAT No. | CS-O-02671 |
| CAS No. | 1132642-95-5 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 320.71 g/mol |
| Mol. For. | C₁₄H₄D₅ClF₃NO₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Efavirenz |
| Purity | 95% |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | FC(F)(F)[C@](C1=CC(Cl)=CC=C1NC2=O)(O2)C#CC3([2H])C([2H])([2H])C3([2H])[2H] |
| Canonical Smiles | C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F |
| InchIKey | XPOQHMRABVBWPR-XWJABCKYSA-N |
| Inchl | InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1/i1D2,2D2,8D |
| IUPAC | (4S)-6-chloro-4-[2-(1,2,2,3,3-pentadeuteriocyclopropyl)ethynyl]-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Efavirenz D5 is a medication that is commonly used to treat HIV infection. It belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs), which work by blocking the activity of the HIV reverse transcriptase enzyme. This enzyme is responsible for converting viral RNA into DNA, which can then be integrated into the host cell's genome and lead to the production of new virus particles.
Efavirenz D5 is chemically similar to the non-deuterated version of the drug, Efavirenz. However, it contains five deuterium atoms, which can be used in pharmacokinetic studies to track the drug's metabolism and distribution in the body. This can provide valuable information on the drug's safety and efficacy, as well as help to optimize dosing regimens.
The recommended dosage of Efavirenz D5 varies depending on the patient's age, weight, and other medical conditions. It is typically taken once daily, either alone or in combination with other antiretroviral medications. Common side effects of the drug include headache, dizziness, nausea, and rash. Less frequently, it can cause more serious side effects such as liver toxicity or psychiatric symptoms.
In conclusion, Efavirenz D5 is an important medication for the treatment of HIV infection, and its chemical properties make it useful for pharmacokinetic studies. However, like all medications, it should be used only under the guidance of a healthcare professional and with careful monitoring for potential side effects.
Get an Instant Quote
Related Compounds
rac 7-Hydroxy Efavirenz-d4 (Major) | rac 8,14-Dihydroxy Efavirenz-d4 | rac Efavirenz D4 | Efavirenz 13C6 |